MONGERSEN, AN ORAL SMAD7 ANTISENSE OLIGONUCLEOTIDE, IN ACTIVE CROHN’S DISEASE

(1) Department Of Systems Medicine, University Of Tor Vergata, Rome, Italy

(2) Department Of Medicine, University Of Erlangen-Nürnberg, Erlangen, Germany

(3) Department Of Surgery, "l. Sacco" University Hospital , Milan, Italy

(4) Internal Medicine, University Of Pavia, Pavia, Italy

(5) Gastroenterology Unit, Hospital San Camillo-Forlanini, Rome, Italy

(6) Ibd Unit, Catholic University, Rome, Italy

(7) Department Of Pathophysiology And Transplantation, University Of Milan, Milan, Italy

(8) Surgical And Gastroenterological Oncology, University Of Padova, Padova, Italy

(9) Gastroenterology Sod2, Aou Careggi University Hospital, Florence, Italy

(10) Department Of Biomedical Sciences, University Of Milan, Milan, Italy

(11) Division Of Gastroenterology, “casa Sollievo Sofferenza” Hospital, Irccs, San Giovanni Rotondo, Italy

(12) Department Of Surgery, "l. Sacco" University Hospital, Milan, Italy

(13) Gastroenterology And Hepatology Unit, University Of Genoa, Genoa, Italy

(14) Ibd Unit, Sandro Pertini Hospital, Rome, Italy

(15) “villa Sofia-Cervello” Hospital, University Of Palermo, Palermo, Italy



This item was part of the New drugs in IBD session at UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)